CRANBURY, N.J.--(BUSINESS WIRE)--Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education (CME), announces the full agenda for the 1st Annual International Congress on the Future of Neurology™. The conference will be held Sept. 27-28 at the InterContinental New York Time Square in New York City.
“We are excited to present our inaugural CME-Certified neurology congress in New York City this year,” said Phil Talamo, president of PER®. “This new meeting is specifically designed in an interactive format for clinicians treating patients with neurologic disorders, and we look forward to bringing participants together with world-renowned experts to share new data, as well as evolving best practices, to help attendees provide better patient care.”
The 1st Annual International Congress on the Future of Neurology™ is a two-day comprehensive meeting that will review the latest data and best practices for treating patients in the eight core areas of neurological disorders: dementia and Alzheimer’s disease, epilepsy, headache and migraine, movement disorders, multiple sclerosis, neuromuscular disorders, stroke and sleep disorders. During this meeting, Stephen Silberstein, M.D., will be joined by 25 world-renowned experts across multiple therapeutic areas. The impact of new evidence and novel agents in the treatment of neurologic disorders will be covered through a series of data presentations, case-based discussions and robust Q&A sessions.
Accredited by the Accreditation Council for Continuing Medical Education and approved by the California Board of Registered Nursing, this congress provides attendees with the opportunity to earn up to 15.0 AMA PRA Category 1 Credits™ and nursing contact hours.
For more information and to view the agenda or register, click here.
About Physicians’ Education Resource® (PER®)
Since 1995, PER® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. While continuing to expand into topics outside oncology, PER® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is part of the Cranbury, New Jersey-based MJH Associates, Inc., family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.